AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cook, J. A.
Right arrow Articles by Young, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cook, J. A.
Right arrow Articles by Young, M.
January 2002, Vol 92, No. 1 | American Journal of Public Health 82-87
© 2002 American Public Health Association

RESEARCH AND PRACTICE

Use of Highly Active Antiretroviral Therapy in a Cohort of HIV-Seropositive Women

Judith A. Cook, PhD, Mardge H. Cohen, MD, Dennis Grey, BA, Lynn Kirstein, MS, Jane Burke, MS, Kathryn Anastos, MD, Herminia Palacio, MD, Jean Richardson, DrPH, Tracey E. Wilson, PhD and Mary Young, MD

Judith A. Cook, Dennis Grey, and Jane Burke are with the Department of Psychiatry, University of Illinois at Chicago. Mardge H. Cohen is with the Core Center, Cook County Hospital, Chicago. Lynn Kirstein is with the Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Md. Kathryn Anastos is with the Department of Medicine, Montefiore Medical Center, Bronx, NY. Herminia Palacio is with the Division of Population Health and Prevention, San Francisco Department of Public Health, San Francisco, Calif. Jean Richardson is with the Department of Preventive Medicine, University of Southern California, Los Angeles. Tracey E. Wilson is with the Department of Preventive Medicine and Community Health, State University of New York Health Science Center at Brooklyn. Mary Young is with the Department of Medicine, Georgetown University Medical Center, Washington, DC.

Correspondence: Requests for reprints should be sent to Judith A. Cook, PhD, Mental Health Services Research Program, Department of Psychiatry, University of Illinois at Chicago, 104 S Michigan Ave, Suite 900, Chicago, IL 60603 (e-mail: cook{at}ripco.com).

Objectives. This study examined longitudinal trends in use of highly active antiretroviral therapy (HAART) among a cohort of HIV-positive participants in the Women's Interagency HIV Study.

Methods. Beginning in 1994, 1690 HIV-positive women reported detailed information about their use of antiretroviral therapy at 6-month study visits. Multivariate logistic and Cox regression analyses were used to estimate the likelihood of antiretroviral therapy and HAART use among women with study visits preceding and following HAART availability.

Results. Before the availability of HAART, the cohort's likelihood of any antiretroviral therapy use was associated with clinical indicators (CD4 count, viral load, symptom presence) as well as behavioral factors (abstaining from drug and alcohol use, participating in clinical trials). After HAART became commercially available, newly emerging predictors included college education, private insurance, absence of injection drug use history, and not being African American.

Conclusions. After the penetration of HAART into this cohort, additional differences emerged between HAART users and nonusers. These findings can inform public health efforts to enhance women's access to the most effective types of therapy.




This article has been cited by other articles:


Home page
 PediatricsHome page
D. J. Merenstein, M. F. Schneider, C. Cox, R. Schwartz, K. Weber, E. Robison, M. Gandhi, J. Richardson, and M. W. Plankey
Association Between Living With Children and Adherence to Highly Active Antiretroviral Therapy in the Women's Interagency HIV Study
Pediatrics, April 1, 2008; 121(4): e787 - e793.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
R. M. Melendez, T. A. Exner, A. A. Ehrhardt, B. Dodge, R. H. Remien, M.-J. Rotheram-Borus, M. Lightfoot, D. Hong, and The National Institute Of Mental Health Healthy Li
Health and Health Care Among Male-to-Female Transgender Persons Who Are HIV Positive
Am J Public Health, June 1, 2006; 96(6): 1034 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
J. K. Burke-Miller, J. A. Cook, M. H. Cohen, N. A. Hessol, T. E. Wilson, J. L. Richardson, P. Williams, and S. J. Gange
Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and Satisfaction With Care Among Women Living With HIV/AIDS
Am J Public Health, June 1, 2006; 96(6): 1044 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
J. G. Feldman, H. Minkoff, M. F. Schneider, S. J. Gange, M. Cohen, D. H. Watts, M. Gandhi, R. S. Mocharnuk, and K. Anastos
Association of Cigarette Smoking With HIV Prognosis Among Women in the HAART Era: A Report From the Women's Interagency HIV Study
Am J Public Health, June 1, 2006; 96(6): 1060 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
M. C. Bacon, V. von Wyl, C. Alden, G. Sharp, E. Robison, N. Hessol, S. Gange, Y. Barranday, S. Holman, K. Weber, et al.
The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench
Clin. Vaccine Immunol., September 1, 2005; 12(9): 1013 - 1019.
[Full Text] [PDF]

Home page
 J Health PsycholHome page
P. N. Halkitis, A. H. Kutnick, and S. Slater
The Social Realities of Adherence to Protease Inhibitor Regimens: Substance Use, Health Care and Psychological States
J Health Psychol, July 1, 2005; 10(4): 545 - 558.
[Abstract] [PDF]

Home page
 Am. J. Public HealthHome page
J. A. Cook, D. Grey, J. Burke, M. H. Cohen, A. C. Gurtman, J. L. Richardson, T. E. Wilson, M. A. Young, and N. A. Hessol
Depressive Symptoms and AIDS-Related Mortality Among a Multisite Cohort of HIV-Positive Women
Am J Public Health, July 1, 2004; 94(7): 1133 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
T. E. Wilson, M. E. Gore, R. Greenblatt, M. Cohen, H. Minkoff, S. Silver, E. Robison, A. Levine, and S. J. Gange
Changes in Sexual Behavior Among HIV-Infected Women After Initiation of HAART
Am J Public Health, July 1, 2004; 94(7): 1141 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
M. H. Cohen, J. A. Cook, D. Grey, M. Young, L. H. Hanau, P. Tien, A. M. Levine, and T. E. Wilson
Medically Eligible Women Who Do Not Use HAART: The Importance of Abuse, Drug Use, and Race
Am J Public Health, July 1, 2004; 94(7): 1147 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. Anastos, Y. Barron, M. H. Cohen, R. M. Greenblatt, H. Minkoff, A. Levine, M. Young, and S. J. Gange
The Prognostic Importance of Changes in CD4+ Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy
Ann Intern Med, February 17, 2004; 140(4): 256 - 264.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
D. Greenspan, S.J. Gange, J.A. Phelan, M. Navazesh, M.E.A.F. Alves, L.A. MacPhail, R. Mulligan, and J.S. Greenspan
Incidence of Oral Lesions in HIV-1-infected Women: Reduction with HAART
J. Dent. Res., February 1, 2004; 83(2): 145 - 150.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Public Health Association